Cargando…
Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations
DMD gene mutations have been associated with the development of Dystrophinopathies. Interestingly, it has been recently reported that DMD is involved in the development and progression of myogenic tumors, assigning DMD a tumor suppressor activity in these types of cancer. However, there are only few...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352069/ https://www.ncbi.nlm.nih.gov/pubmed/27391342 http://dx.doi.org/10.18632/oncotarget.10426 |